Related Experiment Video
Updated: Jan 12, 2026

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions
Published on: October 2, 2018
Caffeine Supplementation and Hair: A Systematic Review
Background:
While caffeine has been proposed to stimulate hair growth, its safety and efficacy remain unclear. This systematic review evaluates the effects of caffeine interventions on hair loss and growth outcomes.
Methods:
A systematic review of seven databases, including PubMed, Medline, and Embase, was conducted in August 2023. Original studies investigating caffeine's effects on hair loss were included. Study quality was assessed using the National Institute of Health Study Quality Assessment Tools. Outcomes of interest included caffeine intervention types and their effects on hair growth.
Results:
Of 587 citations, nine studies met the inclusion criteria: five randomized controlled trials, three prospective cohort studies, and one twin-twin cohort study. Most studies investigated topical caffeine; one assessed oral caffeine intake. Topical caffeine consistently demonstrated hair growth or reduced hair loss with minimal adverse effects. However, none of the studies used tattooed or marked scalp areas for hair counts.
Conclusions:
Caffeine appears to be a safe and promising potential treatment for hair loss. Topical caffeine shows potential as a therapeutic option, though further large-scale randomized controlled trials with standardized outcome measures are needed.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

